Logo image of HERMA.OL

HERMANA HOLDING ASA (HERMA.OL) Stock Fundamental Analysis

OSL:HERMA - Euronext Oslo - NO0013401380 - Common Stock - Currency: NOK

13  -0.35 (-2.62%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to HERMA. HERMA was compared to 35 industry peers in the Energy Equipment & Services industry. No worries on liquidiy or solvency for HERMA as it has an excellent financial health rating, but there are worries on the profitability. HERMA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year HERMA was profitable.
HERMA had a negative operating cash flow in the past year.
HERMA.OL Yearly Net Income VS EBIT VS OCF VS FCFHERMA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.78%, HERMA is in line with its industry, outperforming 42.86% of the companies in the same industry.
HERMA has a Return On Equity of 2.80%. This is in the lower half of the industry: HERMA underperforms 74.29% of its industry peers.
Industry RankSector Rank
ROA 2.78%
ROE 2.8%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HERMA.OL Yearly ROA, ROE, ROICHERMA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 200 400 600

1.3 Margins

With an excellent Profit Margin value of 47.89%, HERMA belongs to the best of the industry, outperforming 97.14% of the companies in the same industry.
In the last couple of years the Profit Margin of HERMA has declined.
The Operating Margin and Gross Margin are not available for HERMA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 47.89%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-22.65%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HERMA.OL Yearly Profit, Operating, Gross MarginsHERMA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -100 -200

7

2. Health

2.1 Basic Checks

HERMA has about the same amout of shares outstanding than it did 1 year ago.
HERMA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HERMA.OL Yearly Shares OutstandingHERMA.OL Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M 10M
HERMA.OL Yearly Total Debt VS Total AssetsHERMA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

There is no outstanding debt for HERMA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
HERMA.OL Yearly LT Debt VS Equity VS FCFHERMA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 127.33 indicates that HERMA has no problem at all paying its short term obligations.
The Current ratio of HERMA (127.33) is better than 97.14% of its industry peers.
A Quick Ratio of 127.33 indicates that HERMA has no problem at all paying its short term obligations.
HERMA's Quick ratio of 127.33 is amongst the best of the industry. HERMA outperforms 97.14% of its industry peers.
Industry RankSector Rank
Current Ratio 127.33
Quick Ratio 127.33
HERMA.OL Yearly Current Assets VS Current LiabilitesHERMA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M 80M 100M

1

3. Growth

3.1 Past

HERMA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -65.30%.
The earnings per share for HERMA have been decreasing by -49.24% on average. This is quite bad
Looking at the last year, HERMA shows a very negative growth in Revenue. The Revenue has decreased by -62.14% in the last year.
Measured over the past years, HERMA shows a very negative growth in Revenue. The Revenue has been decreasing by -34.38% on average per year.
EPS 1Y (TTM)-65.3%
EPS 3Y-49.24%
EPS 5YN/A
EPS Q2Q%528.16%
Revenue 1Y (TTM)-62.14%
Revenue growth 3Y-34.38%
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

Based on estimates for the next years, HERMA will show a very negative growth in Earnings Per Share. The EPS will decrease by -115.44% on average per year.
The Revenue is expected to decrease by -25.99% on average over the next years. This is quite bad
EPS Next Y-900%
EPS Next 2Y-216.23%
EPS Next 3Y-115.44%
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HERMA.OL Yearly Revenue VS EstimatesHERMA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 20M 40M 60M 80M
HERMA.OL Yearly EPS VS EstimatesHERMA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 -0.2 -0.4 -0.6

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 52.00, the valuation of HERMA can be described as expensive.
Based on the Price/Earnings ratio, HERMA is valued a bit more expensive than 77.14% of the companies in the same industry.
When comparing the Price/Earnings ratio of HERMA to the average of the S&P500 Index (27.91), we can say HERMA is valued expensively.
HERMA is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 52
Fwd PE N/A
HERMA.OL Price Earnings VS Forward Price EarningsHERMA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HERMA.OL Per share dataHERMA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

HERMA's earnings are expected to decrease with -115.44% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-216.23%
EPS Next 3Y-115.44%

0

5. Dividend

5.1 Amount

HERMA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HERMANA HOLDING ASA

OSL:HERMA (7/29/2025, 7:00:00 PM)

13

-0.35 (-2.62%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.22%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap174.46M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 52
Fwd PE N/A
P/S 24.57
P/FCF N/A
P/OCF N/A
P/B 1.44
P/tB 1.44
EV/EBITDA N/A
EPS(TTM)0.25
EY1.92%
EPS(NY)-0.62
Fwd EYN/A
FCF(TTM)-0.63
FCFYN/A
OCF(TTM)-0.63
OCFYN/A
SpS0.53
BVpS9.05
TBVpS9.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.78%
ROE 2.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 47.89%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-22.65%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 127.33
Quick Ratio 127.33
Altman-Z N/A
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65.3%
EPS 3Y-49.24%
EPS 5YN/A
EPS Q2Q%528.16%
EPS Next Y-900%
EPS Next 2Y-216.23%
EPS Next 3Y-115.44%
EPS Next 5YN/A
Revenue 1Y (TTM)-62.14%
Revenue growth 3Y-34.38%
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5YN/A
EBIT growth 1Y-396.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year0%
EBIT Next 3Y0%
EBIT Next 5YN/A
FCF growth 1Y-110.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-110.47%
OCF growth 3YN/A
OCF growth 5YN/A